Using gluten detection technology and telemedicine to manage celiac disease
Official title: Gluten Technology and Education for Celiac Health
Run by Columbia University · NCT06059716 · Data updated 2026-11-12
This study is testing if new gluten detection tools used with online support from dietitians can help newly diagnosed adults with celiac disease manage their condition better and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 4 sites (Chicago, Illinois and 3 other locations) |
| Status | Recruiting |
| Started | October 8, 2024 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2028 |
| Registry record updated | June 10, 2026 |
| Trial ID | NCT06059716 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-75 who have been diagnosed with celiac disease within the last four months and are willing to use gluten detection technology.
✕Probably not a fit
Patients who are currently pregnant, not planning to follow a gluten-free diet, or participating in another clinical trial may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to conduct a multi-center randomized controlled trial to evaluate the effectiveness of novel gluten detection technologies combined with telemedicine for managing celiac disease in newly diagnosed adults. The study will focus on improving mucosal recovery and promoting long-term monitoring practices in celiac disease management. Participants will utilize gluten detection technology to enhance their awareness of gluten exposure while receiving continuous support from dietitians through telemedicine. The trial addresses the challenges faced by patients in adhering to a strict gluten-free diet and aims to improve their overall quality of life.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the management of celiac disease and improve patients' health outcomes.
How similar studies have gone: While the approach of combining gluten detection technology with telemedicine is innovative, similar studies have shown promise in improving patient management in other chronic conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any gender; Age 18-75 years * Celiac disease diagnosis by serology and duodenal biopsy (corresponding to •Marsh 3 histology), adequate sampling and interpretable villus height to crypt depth ratio upon review by our study pathologist * Diagnosed with celiac disease within 4 months of initial study screening * Willingness to use gluten-detection technology * Not currently using a gluten detection technology that tests for gluten in urine or stool Exclusion Criteria: * Currently pregnant or planning to become pregnant during the study * Not planning to follow a gluten-free diet * Concurrent participation in a clinical trial of an experimental pharmacologic agent (for any condition).
Where it's running
-
University of Chicago Medical Center
Chicago, Illinois, United States Recruiting -
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Recruiting -
Columbia University Irving Medical Center
New York, New York, United States Recruiting -
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting
Study contacts
- Principal investigator: Benjamin Lebwohl, MD, MS — Columbia University
- Study coordinator: Benjamin Lebwohl, MD, MS
- Email: BL114@cumc.columbia.edu
- Phone: 212-305-9338
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mediterranean diet and processed food in adults with celiac disease on a gluten-free diet
This observational study looks at whether following a Mediterranean-style diet or eating more highly processed foods affects GI symptoms and quality of life in adults with celiac disease who have been on a strict gluten-free diet.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
-
Nutrition and physical activity education for children with celiac disease
This study tests whether a combined nutrition and physical activity education program helps 8- to 12-year-olds with celiac disease improve body health, eating habits, activity, and quality of life while on a gluten-free diet.
-
Liver Fat and Scarring in People Suspected of Non-Celiac Wheat Sensitivity
This study looks to see if people with non-celiac wheat sensitivity have liver fat or fibrosis and how this relates to IBS/FD and celiac disease.
-
Omega-3 fats to reduce inflammation in adults with newly diagnosed celiac disease
This study tests whether adding omega-3 fatty acid supplements to a gluten-free plan helps reduce inflammation and promote intestinal healing in adults who have just been diagnosed with celiac disease.
-
Wheat sensitivity or IBS/functional dyspepsia in relatives of people with celiac disease
This project will test whether adults related to celiac patients have higher rates of non-celiac wheat sensitivity or IBS/functional dyspepsia and whether symptoms change on a wheat-free diet.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.